Skip to main content
Premium Trial:

Request an Annual Quote

Danaher Reaffirms 2012 Guidance, Provides 2013 Estimate

NEW YORK (GenomeWeb News) – Danaher has reaffirmed its net earnings guidance for the fourth quarter and full-year 2012 and provided 2013 guidance in advance of its investor meeting to be held today.

The Washington, DC-based conglomerate, which purchased Beckman Coulter last year, said that it expects to report Q4 earnings-per-share from continuing operations of $.80 to $.85. It expects its full-year net earnings to be $3.14 to $3.19. The consensus Wall Street estimate for the fourth quarter is $.83 and for the full year is $3.16.

Danaher also said it anticipates its FY 2013 net earnings to be between $3.40 and $3.55. That guidance assumes core revenue growth of between 1 percent and 4 percent for the year and includes earnings attributable to the firm's Apex Tool Group, which Danaher is in the process of divesting. Analysts, on average, expect EPS of $3.50 for FY 2013.

"In a low-growth global environment, the Danaher Business System continues to drive solid margin and cash flow performance across our business," Danaher President and CEO H. Lawrence Culp said in a statement. "We are focused on gaining on gaining market share while remaining active on the acquisition front."

The Scan

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.

Team Presents Cattle Genotype-Tissue Expression Atlas

Using RNA sequences representing thousands of cattle samples, researchers looked at relationships between cattle genotype and tissue expression in Nature Genetics.

Researchers Map Recombination in Khoe-San Population

With whole-genome sequences for dozens of individuals from the Nama population, researchers saw in Genome Biology fine-scale recombination patterns that clustered outside of other populations.

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.